FDA Approves Over-The-Counter Sales Of Emergent BioSolutions Narcan Naloxone Nasal Spray

The U.S. Food and Drug Administration (FDA) approved over-the-counter (OTC) sales of Narcan, a 4 milligram naloxone nasal spray. Naloxone is a medication that rapidly reverses the effects of opioid overdose. The approval was granted to Emergent BioSolutions. The FDA approval means Narcan at this formulation and dosage can be sold online and at any retailer that sells over-the-counter medications. Other formulations and dosages of naloxone will remain available by prescription only.

The timeline for availability and price of this OTC product is determined by the manufacturer. The FDA will work with all stakeholders to . . .